A new open-source software package provides fast, modular tools for extracting interpretable cis-regulatory patterns from deep learning models of the genome.
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion Pharmaceuticals had 5 insider transactions totaling $514,889.42. 4 were Tax Payments worth $436,067.04, and 1 was a Sale worth $78,822.38. Najat Khan accounted for 2 transactions totaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results